Jossie Rotman

Jossie Rotman

Auto-generated profile, based on publicly available information

Jossie Rotman

Centre for Gynaecological Oncology Amsterdam (CGOA): Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AvL), Amsterdam, the Netherlands

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2020 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
JRJossie Rotman
Jossie Rotman
AHA. Marijne Heeren
A. Marijne Heeren
AGAwa A. Gassama
Awa A. Gassama
SLSinead M. Lougheed
Sinead M. Lougheed
NPNoëlle Pocorni
Noëlle Pocorni
TGTanja De Gruijl
Tanja De Gruijl
Purpose: Adenocarcinoma (AC) of the uterine cervix is the second most common type of cervical cancer after squamous cell carcinoma (SCC). Although both subtypes are treated similarly, patients with AC have a worse prognosis. In this study, immunologic features of the tumor microenvironment in these two subsets were pursued with potential therapeutic implications. Experimental Design: The immune microenvironment of primary tumors (PT) and non-metastatic tumor-draining lymph nodes (TDLN) was compared between patients with cervical AC (n = 16) and SCC (n = 20) by polychromatic flow cytometry and by transcriptional profiling of the PT (n = 299) using publicly available data from The Cancer Genome Atlas (TCGA). Results: Flowcytometric analyses revealed intact T-cell differentiation in TDLN but hampered effector T-cell trafficking to the PT in AC, as compared to SCC. TCGA analysis demonstrated higher expression of chemokines involved in effector T-cell homing (CXCL9/10/11) in SCC PT as compared to AC PT, which was highly correlated to a transcriptional signature for type 1 conventional dendritic cells (cDC1). This was consistent with elevated frequencies of CD141+/BDCA3+ cDC1 in PT SCC samples relative to AC and correspondingly elevated levels of CXCL9 and CXCL10 in 24h ex-vivo cultures. Hampered cDC1 recruitment in AC was in turn related to lower transcript levels of cDC1-recruiting chemokines and an elevated β-catenin activation score, and was associated with poor overall survival. Conclusions: Our data have identified an opportunity for the investigation of potentially novel therapeutic interventions in AC of the cervix, i.e. β-catenin inhibition and cDC1 mobilization.

26 January 2021 in Cancer Research
Verified
Journal Article
Open access
PDF file
MKMaryam Khelil
Maryam Khelil
HGHeather Griffin
Heather Griffin
MBMaaike C.G. Bleeker
Maaike C.G. Bleeker
Renske D.M. SteenbergenRenske D.M. Steenbergen
Renske D.M. Steenbergen
KZKe Zheng
Ke Zheng
Ekaterina S. JordanovaEkaterina S. Jordanova
Ekaterina S. Jordanova
Human papillomavirus (HPV) drives high-grade intraepithelial neoplasia and cancer; for unknown reasons, this occurs most often in the cervical transformation zone. Either mutation or HPV E6–driven inhibition of Notch1 can drive neoplastic development in stratified squamous epithelia. However, the contribution of Notch1 and its Delta-like ligands (DLL) to site susceptibility remains poorly understood. Here, we map DLL1/DLL4 expression in cell populations present in normal cervical biopsies by immunofluorescence. In vitro keratinocyte 2D monolayer models, growth assays, and organotypic raft cultures were used to assess the functional role of DLL–Notch signaling in uninfected cells and its modulation by HPV16 in neoplasia. An RNA sequencing–based gene signature was used to suggest the cell of origin of 279 HPV-positive cervical carcinomas from The Cancer Genome Atlas and to relate this to disease prognosis. Finally, the prognostic impact of DLL4 expression was investigated in three independent cervical cancer patient cohorts. Three molecular cervical carcinoma subtypes were identified, with reserve cell tumors the most common and linked to relatively good prognosis. Reserve cells were characterized as DLL1−/DLL4+, a proliferative phenotype that is temporarily observed during squamous metaplasia and wound healing but appears to be sustained by HPV16 E6 in raft models of low-grade and, more prominently, high-grade neoplasia. High expression of DLL4 was associated with an increased likelihood of cervical cancer–associated death and recurrence. Taken together, DLL4–Notch1 signaling reflects a proliferative cellular state transiently present during physiologic processes but inherent to cervical reserve cells, making them strongly resemble neoplastic tissue even before HPV infection has occurred. Significance: This study investigates cervical cancer cell-of-origin populations and describes a DLL–Notch1 phenotype that is associated with disease prognosis and that might help identify cells that are susceptible to HPV-induced carcinogenesis.

31 March 2023
Verified
Other
Open access
MKMaryam Khelil
Maryam Khelil
HGHeather Griffin
Heather Griffin
MBMaaike C.G. Bleeker
Maaike C.G. Bleeker
Renske D.M. SteenbergenRenske D.M. Steenbergen
Renske D.M. Steenbergen
KZKe Zheng
Ke Zheng
Ekaterina S. JordanovaEkaterina S. Jordanova
Ekaterina S. Jordanova
Immunostaining of DLL4 and N1ICD in NIKS monolayers and/or organotypic rafts.

31 March 2023
Verified
Other
Open access
JRJossie Rotman
Jossie Rotman
AHA. Marijne Heeren
A. Marijne Heeren
AGAwa A. Gassama
Awa A. Gassama
SLSinead M. Lougheed
Sinead M. Lougheed
NPNoëlle Pocorni
Noëlle Pocorni
TGTanja D. de Gruijl
Tanja D. de Gruijl
Clinical characteristics of the AC study population

31 March 2023
Verified
Other
Open access
MKMaryam Khelil
Maryam Khelil
HGHeather Griffin
Heather Griffin
MBMaaike C.G. Bleeker
Maaike C.G. Bleeker
Renske D.M. SteenbergenRenske D.M. Steenbergen
Renske D.M. Steenbergen
KZKe Zheng
Ke Zheng
Ekaterina S. JordanovaEkaterina S. Jordanova
Ekaterina S. Jordanova
Clinicopathological characteristics of DLL4/N1ICD risk groups (Institutional cohort)

31 March 2023
Verified
Other
Open access
JRJossie Rotman
Jossie Rotman
AHA. Marijne Heeren
A. Marijne Heeren
AGAwa A. Gassama
Awa A. Gassama
SLSinead M. Lougheed
Sinead M. Lougheed
NPNoëlle Pocorni
Noëlle Pocorni
TGTanja D. de Gruijl
Tanja D. de Gruijl
Purpose:Adenocarcinoma of the uterine cervix is the second most common type of cervical cancer after squamous cell carcinoma (SCC). Although both subtypes are treated similarly, patients with adenocarcinoma have a worse prognosis. In this study, immunologic features of the tumor microenvironment in these two subsets were pursued with potential therapeutic implications.Experimental Design:The immune microenvironment of primary tumors and nonmetastatic tumor-draining lymph nodes (TDLN) was compared between patients with cervical adenocarcinoma (n = 16) and SCC (n = 20) by polychromatic flow cytometry and by transcriptional profiling of the primary tumors (n = 299) using publicly available data from The Cancer Genome Atlas (TCGA).Results:Flow cytometric analyses revealed intact T-cell differentiation in TDLNs, but hampered effector T-cell trafficking to the primary tumors in adenocarcinoma, as compared with SCC. TCGA analysis demonstrated higher expression of chemokines involved in effector T-cell homing (CXCL9/10/11) in SCC primary tumors as compared with adenocarcinoma primary tumors, which was highly correlated to a transcriptional signature for type I conventional dendritic cells (cDC1). This was consistent with elevated frequencies of CD141/BDCA3+cDC1 in primary tumor SCC samples relative to adenocarcinoma and correspondingly elevated levels of CXCL9 and CXCL10 in 24-hour ex vivo cultures. Hampered cDC1 recruitment in adenocarcinoma was in turn related to lower transcript levels of cDC1-recruiting chemokines and an elevated β-catenin activation score and was associated with poor overall survival.Conclusions:Our data have identified an opportunity for the investigation of potentially novel therapeutic interventions in adenocarcinoma of the cervix, that is, β-catenin inhibition and cDC1 mobilization.